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INTRODUCTION
Psoriasis is a chronic inflammatory dermatological 
disease that has a major impact on the quality of life 
of patients suffering from it [1]. It is a complex health 
disorder occurring from an interaction of multiple 
genes, the immune system, and the impact of external 
factors [2]. The physical symptoms of psoriasis 
negatively affect health and social relationships [1]. In 
a survey by the National Psoriasis Foundation, almost 
75% of patients believed that psoriasis had a moderate 
to large negative impact on their quality of life (QoL), 
with alterations in their daily activities [3]. Many 
patients report moderate to extreme feelings of anxiety, 
anger, and depression and a higher frequency of suicidal 
ideation [1]. Its severity is measured on the basis of skin 
changes (erythema, induration, and desquamation) 
and the size of the affected skin [4]. The influence 
of social function includes informal and intimate 
relationships with other people, avoiding contact, and 
feeling stigmatized. Psychological function is impaired 
by the reduction of self-esteem and the inability to 
control the progression of the disease and its impact 
on the quality of daily life and activities, leading to 
psychological disorders such as anxiety and depression 
and even to the use of psychotropic substances and 
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formation of suicidal thoughts [5]. Skin diseases are the 
most common somatic causes of psychological disorders 
and, conversely, under the influence of a psychological 
disorder, there is usually a cutaneous manifestation [6]. 
This is the main reason for conducting this research 
during the COVID-19 pandemic, a time when most of 
the population is under constant stress.
Psoriasis and Quality of Life
The World Health Organization defines quality of 
life (QoL) as “an individual’s perception of their 
position in life in the context of the culture and 
value systems in which they live and in relation to 
their goals, expectations, standards and concerns.” 
Quality of life is a general perception of one’s life and 
an estimation of the degree to which it meets their 
expectations. Different aspects of life can be taken to 
assess such quality [7]. A number of researchers agree 
that predominantly the most important things in 
this measurement are health, emotional and material 
well-being, interpersonal relationships, and work. 
Importantly, psoriasis as a disease covers all these 
aspects and factors, which makes its impact even more 
profound. What further increases the influence of the 
disease on one’s quality of life is that it manifests itself 
on the skin, an external organ most and first exposed 
to the scrutiny of others. Psoriasis has a significant 
impact on one’s self-perception and self-evaluation. 
According to some authors, the improvement of the 
clinical appearance is of great importance for the 
improvement of the patient’s psychological situation, 
which will positively impact their quality of life [8]. The 
assessment of the quality of life of people suffering from 
psoriasis employs a number of questionnaires designed 
for this purpose. In our research, we chose to use the 
Dermatological Life Quality Index (DLQI).
Aim of the Research
This research is aimed at determining the quality of life 
of patients with psoriasis, in other words, at determining 
their satisfaction with the current level of functioning 
in terms of what they consider possible and ideal. The 
psychological reaction to the disease varies from person 
to person: some find it extremely difficult to deal with 
even a small advancement of the disease, while others 
cope successfully with more severe manifestations. 
The way one deals with psoriasis depends on its 
perception—a construction that has recently been 
studied in the field of health psychology [8]. Given the 
impact that psoriasis can have on daily functioning, 
what comes to light is the need for more studies and 
research that could foreground the importance of this 
issue, help in creating new methods of therapy, and 
bring more attention to the mental health of these 
patients, as well as raise the collective awareness of the 
nature of what psoriasis is.
MATERIALS AND METHODS
In our research, we employed two questionnaires. 
One collected particulars such as the patient’s age 
and gender. The other was a DLQI (Dermatological 
Life Quality Index) questionnaire, for which we have 
a license [9].
The purpose of a DLQI questionnaire is to determine 
how much a skin concern affects one’s life. It was 
designed in the 1980s as a unified tool for measuring 
the impact of skin disease on the quality of life of 
patients. It consists of ten questions related to the 
following: symptoms and feelings, daily activities such 
as shopping, housework, leisure activities, work, school, 
personal relationships, and treatment. The DLQI is 
defined as the sum of scores for each of the questions, 
resulting in a maximum of 30 (extremely large effect 
on the patient’s life) and a minimum of 0 (no effect at 
all on the patient’s life). The higher the score, the more 
quality of life is impaired [9]. The answers are scored 
as follows: “not at all” at 0, “a little” at 1, “moderately” 
at 2, and “a lot” at 3. The questionnaire is intended for 
persons older than 16 years.
Population and Sample
One hundred six respondents who were medically 
treated or receiving appropriate therapy were included 
in the study. The response of patients who took active 
part in the survey was 82.3% (Fig. 1). The respondents 
were divided accordingly by gender and age. Due to the 
current epidemiological situation, the questionnaire 
was completed by patients who came for a control 
examination, and most of them were contacted by 
phone; some completed the questionnaires online. All 
patients with a history of psoriasis who were treated 
regularly at our institutions, as well as the patients who 
were visiting private health institutions, and agreed to 
complete the questionnaire took part in the research.
Twenty-four respondents were thirty and younger, fifty-
two respondents were between 31 and 60 years of age, 
and thirty were older than 61 (Table 1). The youngest 
patient was 18 years old, and the oldest was 82.
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RESULTS
According to the DLQI questionnaire—whose purpose 
is to determine how much a skin concern affects one’s 
quality of life—respondents answered ten questions 
that were scored from 0 to 3.
The lowest DLQI score, which was 3, was obtained 
from 4 (3.7%) respondents, and the highest, which 
was 29, was obtained from 6 (5.6%) respondents. 
No maximum score of 30 was recorded. The most 
commonly obtained scores were 4 and 8, among which 
a score of 4 was given to 19 (17.9%) respondents. and 
a score of 8 was given to 21 (19.8%) respondents. 
16 (15.09%) respondents had a score of 15, and the 
same number of respondents had a score of 16; 14 
(13.2%) respondents had a score of 21, and 10 (9,4%) 
respondents had a score of 17.
As many as 69.8% of the respondents had problems 
with the affected parts of the skin rated as answers 
“moderately” or “a lot” (Fig. 2). The skin was itchy, 
tingly, sore, or inflamed. Choosing the appropriate 
clothes was a problem for 64.1% of the respondents. 
Treating the skin issues at home in terms of dirtiness 
and time consumption was a problem for 54.7% 
of the respondents. In performing daily activities, 
such as shopping and working at home or in the 
garden, 52.8% of the respondents had problems 
rated as answers “moderately” or “a lot.” 49% of 
the respondents felt embarrassed by the condition 
of their skin. Social activities and free time were 
problems rated as answers “moderately” or “a lot” 
for 45.2% of the respondents. The relationship with 
the partner, friends, and relatives was a considerable 
problem for 39.6% of the respondents. 37.7% of the 
respondents experienced sexual difficulties, 26.4% 
experienced problems with sports activities, while 
only 13.2% reported difficulties with work activities 
and studying.
In terms of health problems, female respondents gave 
lower DLQI values than male respondents (Table 2). 
However, by applying the t-test to determine the 
statistical significance of the difference, where 
p ≤ 0.05, the value of t was determined to be -0.48 
(p = 0.31), which means that there was no statistically 
significant difference. As for embarrassment, female 
respondents achieved higher results than male 
respondents, with p = 0.22, which means that there 
was, again, no statistically significant difference. 
Daily activities were a more significant problem for 
female respondents, but a p value of 0.28 confirmed 
that the difference was not statistically significant 
either. Choice of clothing was also a considerable 
problem for female respondents, but with p = 0.39 
Table 1: Distribution of respondents by gender and age
N   Up to 30 
years of age
From 31 to 60 
years of age
Above 61 
years of age
Total
Men f   8 24 10 42
% 7.55 22.65 9.43 39.63
Women f 16 28 20 64
% 15.1 26.41 18.86 60.37
Total f 24 52 30 106
% 22.65 49.1 28.3 100
Figure 1: Distribution of respondents by gender.
Figure 2: Areas of life in which respondents experienced moderate 
to signifi cant problems.
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there was no statistically significant difference. As 
for social activities and free time, male respondents 
achieved higher results, but a p value of 0.49 
confirmed that there was no statistically significant 
difference. Sports activities were shown to be a 
more significant problem for males but there was 
no statistically significant difference, with p = 0.36. 
Work activities and studying were a more significant 
problem for males, but a p of 0.4 showed that there 
was no statistically significant difference. When it 
comes to the relationship with the partner, friends, 
and relatives, male respondents gave higher scores, 
but p = 0.29 confirmed that there was no statistically 
significant difference. Regarding sexual difficulties, 
male respondents gave higher scores and a p value 
of 0.03 indicated a statistically significant difference 
at the level of significance of 0.05. Treatment of the 
ailing parts of the skin was a more palpable problem 
for males, but a p value of 0.38 did not indicate a 
statistically significant difference.
DISCUSSION
The research results were collected in order to 
determine the quality of life of psoriatic patients, in 
other words, to determine their satisfaction with the 
current level of functioning in relation to what they 
consider possible and ideal, as well as minimizing the 
risk of depression. The questionnaires made it possible 
to collect detailed information about numerous aspects 
of health disturbed by psoriasis. Patients with psoriasis 
were found to experience a range of challenges and 
obstacles on a daily basis that impaired their quality 
of life, either through health manifestations (itching, 
pain, inflammation, tingling) or time-consuming skin 
treatments, embarrassment, choice of appropriate 
clothing, and troubles with daily tasks.
 CONCLUSION
Psoriasis has a profound impact on quality of life, 
even though there prevails a belief that skin diseases 
are less serious and, because they might not be as 
life-threatening, health workers devote to them less 
attention. This belief is, however, wrong, because skin 
diseases, especially psoriasis, have a huge impact on the 
patient’s mental health, for instance, on physical, social, 
and psychological aspects of life. Research on this issue 
is becoming progressively more necessary in the fields 
of science and medicine. Given that the skin is the 
largest organ and its diseases have great repercussions, 
they impact not only the quality of life of the patient 
but also of their families. We concluded that, when 
compared with the results of studies performed several 
years ago [10,11], together with this study performed 
during the COVID-19 pandemic, there are no major 
differences in terms of quality of life in patients with 
psoriasis.
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